TP53 and ovarian carcinoma: Another study showed that wild‐type TP53 negatively regulated BORIS expression by binding BORIS promoter and interacting with the transcription factor Sp1 in epithelial ovarian cancer; this relationship may be the reason for the high expression of BORIS in epithelial ovarian cancer.27